LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

(NasdaqGM:LBRX), NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Kaya Pai Panandiker, the new Chief Commercial Officer of LB Pharmaceuticals, an equity award outside of, but subject to the terms and conditions of, the LB Pharmaceuticals Inc 2025 […]

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 10, 2025 NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Kaya Pai Panandiker, the new Chief Commercial Officer of LB Pharmaceuticals, an equity

JHX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX

New York, New York–(Newsfile Corp. – December 10, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of James Hardie Industries plc (NYSE: JHX) between May 20, 2025 through August 18, 2025, both dates inclusive (the “Class Period”) of the important December 23, 2025 lead plaintiff deadline. SO

Transcontinental Inc. Announces Results for the Fourth Quarter and Fiscal Year 2025

(TSX:TCL-A),(TSX:TCL-B), Highlights Revenues of $732.4 million for the quarter ended October 26, 2025; operating earnings of $66.9 million; and net earnings attributable to shareholders of the Corporation of $42.9 million ($0.51 per share). Adjusted operating earnings before depreciation and amortization(1) of $137.6 million for the quarter ended October 26, 2025; adjusted operating earnings(1) of $100.6

BluMetric Closes Acquisition of DS Consultants

Ottawa, Ontario–(Newsfile Corp. – December 10, 2025) – BluMetric Environmental Inc. (TSXV: BLM) (“BluMetric” or the “Company“), a full-service environmental consulting and engineering cleantech firm, announced the closing of its previously announced acquisition of DS Consultants Ltd. (“DS Consultants“). Pursuant to the terms of the share purchase agreement dated December 1, 2025, BluMetric acquired all

Imagine Lithium Expands Strategic Land Package at Jackpot Project by 45%; Grants Options

Vancouver, British Columbia–(Newsfile Corp. – December 10, 2025) – IMAGINE LITHIUM INC. (TSXV: ILI) (OTCQB: ARXRF) (the “Company” or “Imagine”) is pleased to announce a strategic land acquisition in the prolific Georgia Lake Pegmatite Field (GLPF), increasing its overall prolific exploration area by 45% at its 100%-owned Jackpot Lithium Project, located near Thunder Bay, Ontario, Canada. The addition

TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board

Vancouver, British Columbia–(Newsfile Corp. – December 10, 2025) – TempraMed Technologies Ltd. (CSE: VIVI) (“TempraMed” or the “Company“), a medical technology innovator transforming how temperature-sensitive medications are stored and managed, today announced the appointment of Professor Dr. Lutz Heinemann, one of the world’s foremost diabetes researchers, to its Scientific Advisory Board. His appointment further enhances

Transcontinental Inc. Announces Results for the Fourth Quarter and Fiscal Year 2025

Transcontinental Inc. Announces Results for the Fourth Quarter and Fiscal Year 2025 GlobeNewswire December 10, 2025 Highlights Revenues of $732.4 million for the quarter ended October 26, 2025; operating earnings of $66.9 million; and net earnings attributable to shareholders of the Corporation of $42.9 million ($0.51 per share). Adjusted operating earnings before depreciation and amortization(1)

West Fraser Declares Dividend

WestFraser Timber Co. Ltd. (“West Fraser” or the “Company”) (TSX and NYSE: WFG) has declared a quarterly dividend of US$0.32 per share on the Common shares and Class B Common shares in the capital of the Company, payable on January14, 2026 to shareholders of record on December29, 2025. Dividends are designated to be eligible dividends

Lument Finance Trust Closes $664 Million Commercial Real Estate CLO

Lument Finance Trust, Inc.(NYSE:LFT) (“we,”; “LFT” or the “Company”) today announced that it closed LMNT 2025-FL3, a $663.8 million managed Commercial Real Estate Collateralized Loan Obligation (“CRE CLO”). The Company placed approximately $585.0 million of investment grade securities with institutional investors, providingLFT with term financing on a non-mark-to-market, non-recourse basis. LMNT 2025-FL3 includes a 30-month

Scroll to Top